Balance Sheet - ArriVent BioPharma, Inc. (AVBP)
$(Billion, Million)| Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | |
|---|---|---|---|---|---|
| Total cash and short-term investments | 0.31 | 0.22 | 0.15 | 0.16 | 0.04 |
| Accounts receivable, net | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 0.00 | ||||
| Other current assets | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 |
| Total current assets | 0.33 | 0.23 | 0.16 | 0.18 | 0.04 |
| Total non-current assets | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Total assets | 0.33 | 0.27 | 0.16 | 0.18 | 0.04 |
| Total current liabilities | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 |
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 |
| Total stockholders' equity | 0.31 | 0.26 | 0.15 | 0.17 | 0.04 |
| Common shares outstanding | 38 | 31 | 32 | 33 | 1 |
Show Quarterly Balance Sheet
Balance Sheet - ArriVent BioPharma, Inc. (AVBP)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.33 | 0.31 | 0.30 | 0.24 | 0.18 | 0.22 | 0.28 | 0.30 | 0.32 | 0.15 | 0.17 | 0.18 | 0.16 | 0.16 | 0.00 | 0.00 | 0.04 |
| Accounts receivable, net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Other current assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | -0.04 | |||
| Total current assets | 0.35 | 0.33 | 0.32 | 0.25 | 0.19 | 0.23 | 0.29 | 0.31 | 0.33 | 0.16 | 0.18 | 0.20 | 0.16 | 0.18 | 0.04 | ||
| Total non-current assets | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.16 | 0.00 | -0.04 | ||
| Total assets | 0.35 | 0.33 | 0.33 | 0.27 | 0.22 | 0.27 | 0.29 | 0.31 | 0.33 | 0.16 | 0.18 | 0.20 | 0.18 | ||||
| Total current liabilities | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 0.00 | 0.00 | -0.04 | |||
| Total liabilities | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -0.04 | |||
| Total stockholders' equity | 0.32 | 0.31 | 0.30 | 0.25 | 0.20 | 0.26 | 0.28 | 0.30 | 0.32 | 0.15 | 0.17 | 0.19 | 0.17 | 0.17 | 0.04 | ||
| Common shares outstanding | 45 | 38 | 42 | 35 | 34 | 34 | 34 | 34 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 1 | 1 |